Rights and permissions
About this article
Cite this article
Exenatide could be a sweet option for T2DM in the US. Pharmacoecon. Outcomes News 638, 5 (2011). https://doi.org/10.2165/00151234-201106380-00015
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106380-00015